Saliva as a Diagnostic Tool: The ADA Convenes Summit to Chart Path Forward

The ADA Salivary Diagnostics Summit, held June 18, brought together participants from across dentistry, medicine, research, diagnostics, technology, investment, and insurance to discuss the scientific, regulatory, and clinical steps needed to support broader use of saliva-based testing.

The gathering took place in Chicago and was reported on by ADA News on July 20, 2026.

The central question that emerged throughout the day was not whether saliva has potential to support health and wellness, but how dentistry can develop standards, workflows, and evidence-based guidance — along with regulatory approval pathways — that allow dentists to use salivary testing in a consistent manner.

In plain terms, the science of reading health signals from saliva is advancing, but dentistry still needs clear rules for how and when to use it.

Discussion repeatedly returned to the need for validated tests, reference ranges, and clear guidance on how dentists should respond to results. One senior voice from the field noted that saliva-based tools could help dentistry participate more fully in precision medicine by adding objective biochemical information to clinical examinations, and that patient education, risk assessment, and treatment monitoring could all benefit.

The meeting concluded with broad agreement that the profession must define the use cases, validate the tests, develop clinical workflows, and educate both dentists and patients before the technology can be widely incorporated into care.

For patients, the practical takeaway is straightforward: salivary testing is not yet a routine part of dental visits, but the professional groundwork being laid today may make non-invasive, saliva-based health screening a realistic part of preventive dental care in the years ahead.